Related Experiment Videos
MiR-100-5p is involved in severe pneumonia in children by targeting MTOR
Lun Zhang1, Qing Wang2, Shoushan Mo3
1Department of Pediatrics, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi City, China.
Insights
MicroRNA-100-5p (miR-100-5p) is a potential biomarker for severe childhood pneumonia. Its decreased expression is linked to the condition, suggesting a role in disease regulation.
Area of Science:
- Pediatric Respiratory Medicine
- Molecular Biology
- Biomarker Discovery
Background:
- Severe pneumonia in children is a critical illness with significant mortality risks.
- MicroRNA-100-5p (miR-100-5p) is investigated as a potential diagnostic marker for severe pediatric pneumonia.
Purpose of the Study:
- To evaluate the diagnostic value of miR-100-5p in severe pneumonia among children.
- To investigate the role of miR-100-5p in regulating cellular proliferation and inflammation in the context of pneumonia.
Main Methods:
- Serum miR-100-5p expression was analyzed in 200 children.
- In vitro studies involved WI-38 cells treated with lipopolysaccharide (LPS) to assess miR-100-5p function.
- TargetScan and dual-luciferase reporter assays were used to identify and confirm MTOR as a downstream target of miR-100-5p.
Main Results:
- miR-100-5p expression was significantly decreased in children with severe pneumonia, exhibiting high diagnostic accuracy.
- miR-100-5p levels correlated with clinical indicators of disease severity.
- Overexpression of miR-100-5p in LPS-stimulated cells enhanced proliferation and reduced inflammatory markers, while inhibition had opposite effects.
- A negative association was observed between miR-100-5p and MTOR expression in pediatric severe pneumonia patients.
Conclusions:
- miR-100-5p plays a role in severe childhood pneumonia by negatively regulating MTOR.
- miR-100-5p demonstrates potential as a valuable biomarker for diagnosing severe pneumonia in children.
Background:
Severe pneumonia in children is a life-threatening respiratory condition that can lead to severe complications and even mortality. We confirmed the possibility of miR-100-5p as a biomarker in severe pneumonia in children.
Methods:
A total of 200 children were included. The expression of miR-100-5p from serum was detected. WI-38 cells were treated with 10 µg/mL LPS for 24 h. miR-100-5p was overexpressed or inhibited by transfection. In addition, proliferation and inflammatory factors were measured. TargetScan was utilized to forecast the downstream of miR-100-5p. The targeting relationship between miR-100-5p and MTOR was confirmed by the dual-luciferase reporter system. miR-100-5p and MTOR were co-overexpressed to detect the function of both in severe pneumonia in children.
Results:
miR-100-5p expression was decreased and had a high diagnostic value in severe pneumonia in children. The miR-100-5p level was closely related to clinical indicators. In WI-38 cells treated with LPS, overexpression of miR-100-5p increased proliferation and reduced inflammatory factors, while inhibition of miR-100-5p reduced proliferation and increased inflammatory factors. MTOR expression was negatively associated with miR-100-5p expression in severe pneumonia in children.
Conclusions:
miR-100-5p may participate in severe pneumonia in children by negatively regulating MTOR, proving that it might be a biomarker of severe pneumonia in children.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Pneumonia II: Pathophysiology
Atypical Pneumonia
Respiratory Syncytial Virus Disease
Pneumonia I: Introduction